News
Videos
Conferences
Events
Resources
Subscribe

|Articles|April 22, 2015

Dr. Primo Lara Discusses Emerging Therapies in Kidney Cancer

Primo Neary Lara Jr., associate director of Translational Research at the UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.

Primo Neary Lara Jr., associate director of Translational Research and co-leader of the Cancer Therapeutics Program at UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Maureen McBeth

Can Exercise Improve Cancer Survival After Treatment?

ByMaureen McBeth

October 15th 2025

Dr. Anjana Pillai highlights Liver Cancer Awareness Month’s role in promoting liver health, dispelling myths and encouraging early detection and care.

What is the Importance of Recognizing Liver Cancer Awareness Month?

ByDr. Anjana Pillai

October 14th 2025

Dr. Komal Jahaveri

Awareness Sparks Change, Says Dr. Jhaveri on Breast Cancer Month

ByDr. Komal Jhaveri

October 14th 2025

Image of 3 people.

Breast Cancer Awareness Month Isn’t Always “Pink and Pretty”

October 13th 2025

Brittney Nichols

Finding Hope Amidst a Lung Cancer Diagnosis

ByBrittney Nichols

October 10th 2025

Trending on CURE

Navigating Life’s Path With Multiple Myeloma

Can Exercise Improve Cancer Survival After Treatment?

FDA Fast Tracks NG-350A for Some With Advanced Rectal Cancer

My New Normal After Follicular Lymphoma

What the Art of Kintsugi Can Teach During a Cancer Journey

© 2025 MJH Life Sciences^®

All rights reserved.